Consorted public-private partnership approaches to improve preclinical data quality – the perspective of the pharmaceutical industry
- At: 2017 FIP Congress in Stockholm (Sweden)
- Type: Presentation
- By: STECKLER, Thomas (Janssen R&D, Beerse, Belgium)
- Co-author(s): Thomas Steckler: Bioresearch Quality & Compliance, Janssen R&D, Beerse, Belgium
Malcolm Macleod: Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom
Pharmaceutical industry, as well as basic science, depend on robust data and scientific rigor as key drivers for decision making, patent strength and time-to-market, which in turn will determine knowledge gain and availability of new treatments to patients. Recent publications report challenges with the robustness, rigor, and/or validity of.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.